241 related articles for article (PubMed ID: 22417638)
1. Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
Wang Z; Wu M; Wang Y; Li Z; Wang L; Han G; Chen F; Liu Y; Wang K; Zhang A; Meng L; Wang Q
Eur J Med Chem; 2012 May; 51():250-8. PubMed ID: 22417638
[TBL] [Abstract][Full Text] [Related]
2. Expedient synthesis and structure-activity relationships of phenanthroindolizidine and phenanthroquinolizidine alkaloids.
Chuang TH; Lee SJ; Yang CW; Wu PL
Org Biomol Chem; 2006 Mar; 4(5):860-7. PubMed ID: 16493470
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.
Gao W; Bussom S; Grill SP; Gullen EA; Hu YC; Huang X; Zhong S; Kaczmarek C; Gutierrez J; Francis S; Baker DC; Yu S; Cheng YC
Bioorg Med Chem Lett; 2007 Aug; 17(15):4338-42. PubMed ID: 17531481
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities.
de Fatima Pereira M; Rochais C; Dallemagne P
Anticancer Agents Med Chem; 2015; 15(9):1080-91. PubMed ID: 25991426
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric synthesis of phenanthroindolizidine alkaloids with hydroxyl group at the C14 position and evaluation of their antitumor activities.
Ikeda T; Yaegashi T; Matsuzaki T; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Jan; 21(1):342-5. PubMed ID: 21126872
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, anti-tobacco mosaic virus (TMV) activity, and SARs of 7-methoxycryptopleurine derivatives.
Wang Z; Feng A; Cui M; Liu Y; Wang L; Wang Q
Chem Biol Drug Des; 2014 Nov; 84(5):531-42. PubMed ID: 24751111
[TBL] [Abstract][Full Text] [Related]
8. 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.
Liu Y; Qing L; Meng C; Shi J; Yang Y; Wang Z; Han G; Wang Y; Ding J; Meng LH; Wang Q
J Med Chem; 2017 Apr; 60(7):2764-2779. PubMed ID: 28333459
[TBL] [Abstract][Full Text] [Related]
9. Simplification of antitumoral phenanthroindolizidine alkaloids: short synthesis of cytotoxic indolizidinone and pyrrolidine analogs.
Miguélez J; Boto A; Marín R; Díaz M
Eur J Med Chem; 2013 Aug; 66():540-54. PubMed ID: 23845713
[TBL] [Abstract][Full Text] [Related]
10. First discovery and stucture-activity relationship study of phenanthroquinolizidines as novel antiviral agents against tobacco mosaic virus (TMV).
Wang Z; Feng A; Cui M; Liu Y; Wang L; Wang Q
PLoS One; 2012; 7(12):e52933. PubMed ID: 23285230
[TBL] [Abstract][Full Text] [Related]
11. Isolation and biological activities of phenanthroindolizidine and septicine alkaloids from the Formosan Tylophora ovata.
Lee YZ; Huang CW; Yang CW; Hsu HY; Kang IJ; Chao YS; Chen IS; Chang HY; Lee SJ
Planta Med; 2011 Nov; 77(17):1932-8. PubMed ID: 21728149
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, antiviral activity, and SARs of 13a-substituted phenanthroindolizidine alkaloid derivatives.
Su B; Cai C; Deng M; Liang D; Wang L; Wang Q
Bioorg Med Chem Lett; 2014 Jul; 24(13):2881-4. PubMed ID: 24835986
[TBL] [Abstract][Full Text] [Related]
13. C8c-C15 monoseco-analogues of the phenanthroquinolizidine alkaloids julandine and cryptopleurine exhibiting potent anti-angiogenic properties.
Banwell MG; Bezos A; Burns C; Kruszelnicki I; Parish CR; Su S; Sydnes MO
Bioorg Med Chem Lett; 2006 Jan; 16(1):181-5. PubMed ID: 16236503
[TBL] [Abstract][Full Text] [Related]
14. Indolizidine and quinolizidine alkaloids.
Michael JP
Nat Prod Rep; 2008 Feb; 25(1):139-65. PubMed ID: 18250900
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of glycoconjugates of phenanthroindolizidines alkaloids.
Wu M; Han G; Meng C; Wang Z; Liu Y; Wang Q
Mol Divers; 2014 Feb; 18(1):25-37. PubMed ID: 24132551
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity studies of antofine analogues as potential anticancer agents.
Fu Y; Lee SK; Min HY; Lee T; Lee J; Cheng M; Kim S
Bioorg Med Chem Lett; 2007 Jan; 17(1):97-100. PubMed ID: 17049857
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, antiviral activity, and structure-activity relationships (SARs) of two types of structurally novel phenanthroindo/quinolizidine analogues.
Su B; Chen F; Wang L; Wang Q
J Agric Food Chem; 2014 Feb; 62(6):1233-9. PubMed ID: 24467600
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.
Li X; Zhao WL; Jiang JD; Ren KH; Du NN; Li YB; Wang YX; Bi CW; Shao RG; Song DQ
Bioorg Med Chem Lett; 2011 Sep; 21(18):5251-4. PubMed ID: 21807514
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic and anti-HIV phenanthroindolizidine alkaloids from Cryptocarya chinensis.
Wu TS; Sun CR; Lee KH
Nat Prod Commun; 2012 Jun; 7(6):725-7. PubMed ID: 22816292
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of alkaloids: recent advances in the synthesis of phenanthroindolizidine alkaloids.
Burtoloso AC; Bertonha AF; Rosset IG
Curr Top Med Chem; 2014; 14(2):191-9. PubMed ID: 24359202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
